ZYN001
-
Devon-Based Developer of Synthetic Cannabinoid Therapies Narrows Its Focus
Devon’s Zynerba Pharmaceuticals, which develops synthetic cannabinoid therapies, is focusing on several rare and near-rare neurological and psychiatric disorders that have unmet medical needs, writes…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
